Amendment: SEC Form SC 13G/A filed by Kewaunee Scientific Corporation

11/1/24 9:14:13 AM ET

$KEQU

Medical Specialities

Industrials

Get the next $KEQU alert in real time by email

SC 13G/A 1 kewaunee13ga4.htm MINERVA 13GA4 KEWAUNEE sc13g

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 4)*

Kewaunee Scientific Corporation

(Name of Issuer)

Common Stock, $2.50 par value

(Title of Class of Securities)

492854104

(CUSIP Number)

March 28, 2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[ ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[ ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.


CUSIP No.		492854104


1	NAMES OF REPORTING PERSONS:

	Minerva Advisors LLC Minerva Group, LP Minerva GP, LP Minerva GP, Inc. David P. Cohen


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
	(a) [ ]
	(b) [ ]


3	SEC USE ONLY:



4	CITIZENSHIP OR PLACE OF ORGANIZATION:

	Minerva Advisors LLC - Delaware Minerva Group, LP - Delaware Minerva GP, LP - Delaware Minerva GP, Inc. - Pennsylvania David P. Cohen - U.S. Citizen


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5	SOLE VOTING POWER:

			Minerva Advisors LLC* - 107,104 Minerva Group, LP - 107,104 Minerva GP, LP* - 107,104 Minerva GP, Inc.* - 107,104 David P. Cohen* - 107,104 *Each of these reporting persons is deemed a beneficial owner of the 107,104 shares of the Issuer held by Minerva Group, LP.


		6	SHARED VOTING POWER:

			Minerva Advisors LLC - 36,478 David P. Cohen - 36,478 David P. Cohen is deemed a beneficial owner of the 36,478 shares of the Issuer beneficially owned by Minerva Advisors LLC.


		7	SOLE DISPOSITIVE POWER:

			Minerva Advisors LLC* - 107,104 Minerva Group, LP - 107,104 Minerva GP, LP* - 107,104 Minerva GP, Inc.* - 107,104 David P. Cohen* - 107,104 *Each of these reporting persons is deemed a beneficial owner of the 107,104 shares of the Issuer held by Minerva Group, LP.


		8	SHARED DISPOSITIVE POWER:

			Minerva Advisors LLC - 36,478 David P. Cohen - 36,478 David P. Cohen is deemed a beneficial owner of the 36,478 shares of the Issuer beneficially owned by Minerva Advisors LLC.


9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

	Minerva Advisors LLC* - 143,582 Minerva Group, LP - 107,104 Minerva GP, LP* - 107,104 Minerva GP, Inc.* - 107,104 David P. Cohen* - 143,582 *Each of these reporting persons is deemed a beneficial owner of the 107,104 shares of the Issuer held by Minerva Group, LP. David P. Cohen is also deemed a beneficial owner of the 143,582 shares of the Issuer beneficially owned by Minerva Advisors LLC.


10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

	[ ]


11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):

	Minerva Advisors LLC* - 4.99% Minerva Group, LP - 3.73% Minerva GP, LP* - 3.73% Minerva GP, Inc.* - 3.73% David P. Cohen* - 4.99% *Each of these reporting persons is deemed a beneficial owner of the 3.73% of the shares of the Issuer held by Minerva Group, LP. David P. Cohen is also deemed a beneficial owner of the 4.99% of the shares of the Issuer beneficially owned by Minerva Advisors LLC. Based on a total of 2,875,104 shares of the Issuer's Common Shares outstanding as of March 5, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q for the period ended January 31, 2024.


12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

	Minerva Advisors LLC - IA Minerva Group, LP - PN Minerva GP, LP - PN Minerva GP, Inc. - CO David P. Cohen - IN

SCHEDULE 13G


Item 1(a)	Name of Issuer.

	Kewaunee Scientific Corporation

Item 1(b)	Address of Issuer's Principal Executive Offices.

	2700 West Front Street Statesville, North Carolina 28677-2927

Item 2(a)	Name of Person Filing.

	Minerva Advisors LLC Minerva Group, LP Minerva GP, LP Minerva GP, Inc. David P. Cohen

Item 2(b)	Address of Principal Business Office or, if none, Residence.

	50 Monument Road, Suite 201 Bala Cynwyd, PA 19004

Item 2(c)	Citizenship.

	David P. Cohen is a U.S. Citizen. Minerva Advisors LLC, Minerva Group, LP, and Minerva GP, LP are organized under Delaware law. Minerva GP, Inc. is organized under Pennsylvania law.


Item 2(d)	Title of Class of Securities.

	Common Stock, par value $2.50

Item 2(e)	CUSIP Number.

	492854104


Item 3	This statement is not filed pursuant to Rules 13d-1(b), 13d-2(b) or 13d-2(c).


Item 4	Ownership.

	(a)	Amount beneficially owned: Minerva Advisors LLC* - 143,582 Minerva Group, LP - 107,104 Minerva GP, LP* - 107,104 Minerva GP, Inc.* - 107,104 David P. Cohen* - 143,582 *Each of these reporting persons is deemed a beneficial owner of the 107,104 shares of the Issuer held by Minerva Group, LP. David P. Cohen is also deemed a beneficial owner of the 143,582 shares of the Issuer beneficially owned by Minerva Advisors LLC.

	(b)	Percent of Class: Minerva Advisors LLC* - 4.99% Minerva Group, LP - 3.73% Minerva GP, LP* - 3.73% Minerva GP, Inc.* - 3.73% David P. Cohen* - 4.99% *Each of these reporting persons is deemed a beneficial owner of the 3.73% of the shares of the Issuer held by Minerva Group, LP. David P. Cohen is also deemed a beneficial owner of the 4.99% of the shares of the Issuer beneficially owned by Minerva Advisors LLC. Based on a total of 2,875,104 shares of the Issuer's Common Shares outstanding as of March 5, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q for the period ended January 31, 2024.

	(c)	Number of Shares as to which the person has: (i) Sole power to vote or to direct the vote: Minerva Advisors LLC* - 107,104 Minerva Group, LP - 107,104 Minerva GP, LP* - 107,104 Minerva GP, Inc.* - 107,104 David P. Cohen* - 107,104 Each of these reporting persons is deemed a beneficial owner of the 107,104 shares of the Issuer held by Minerva Group, LP. (ii) Shared power to vote or to direct the vote: Minerva Advisors LLC - 36,478 David P. Cohen* - 36,478 *David P. Cohen is deemed a beneficial owner of the 36,478 shares of the Issuer beneficially owned by Minerva Advisors LLC. (iii) Sole power to dispose or to direct the disposition of: Minerva Advisors LLC - 107,104 Minerva Group, LP - 107,104 Minerva GP, LP* - 107,104 Minerva GP, Inc.* - 107,104 David P. Cohen* - 107,104 Each of these reporting persons is deemed a beneficial owner of the 107,104 shares of the Issuer held by Minerva Group, LP. (iv) Shared power to dispose or to direct the disposition of: Minerva Advisors LLC - 36,478 David P. Cohen* - 36,478 **David P. Cohen is deemed a beneficial owner of the 36,478 shares of the Issuer beneficially owned by Minerva Advisors LLC.

Item 5	Ownership of Five Percent or Less of a Class.

	This statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities.

Item 6	Ownership of More Than Five Percent on Behalf of Another Person.

	Not applicable.

Item 7	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported On By the Parent Holding Company or Control Person.

	Not applicable.

Item 8	Identification and Classification of Members of the Group.

	Not applicable.

Item 9	Notice of Dissolution of Group.

	Not applicable.

Item 10	Certification.

	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

MINERVA ADVISORS LLC
Date: October 31, 2024

By:		David P. Cohen, President

		By:		/s/ Beth N. Lowson

				Name: Beth N. Lowson
				Title: Attorney-In-Fact
				DarrowEverett LLP




MINERVA GROUP, LP
Date: October 31, 2024

By:		MINERVA GP, LP, its General Partner

	By:		MINERVA GP, INC., its General Partner

	By:		David P. Cohen, President

		By:		/s/ Beth N. Lowson

				Name: Beth N. Lowson
				Title: Attorney-In-Fact
				DarrowEverett LLP




MINERVA GP, LP
Date: October 31, 2024

By:		MINERVA GP, INC., its General Partner

	By:		David P. Cohen, President

		By:		/s/ Beth N. Lowson

				Name: Beth N. Lowson
				Title: Attorney-In-Fact
				DarrowEverett LLP




MINERVA GP, INC.
Date: October 31, 2024

By:		David P. Cohen

		By:		/s/ Beth N. Lowson

				Name: Beth N. Lowson
				Title: Attorney-In-Fact
				DarrowEverett LLP




DAVID P. COHEN
Date: October 31, 2024

		By:		/s/ Beth N. Lowson

				Name: Beth N. Lowson
				Title: Attorney-In-Fact
				DarrowEverett LLP

POWER OF ATTORNEY

The undersigned does hereby constitute and appoint DarrowEverett LLP, a Rhode Island limited liability partnership, and each of its representatives, signing singly, with full power of substitution, as the true and lawful attorney of the undersigned, and authorizes and designates each of them to sign on behalf of the undersigned, and to file filings and any amendments thereto made by or on behalf of the undersigned in respect of the beneficial ownership of equity securities held by the undersigned, directly, indirectly or beneficially, pursuant to Sections 13(d), 13(f), 13(g) and 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules and regulations thereunder. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned's responsibilities to comply with Sections 13(d), 13(f), 13(g) or 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until withdrawn by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 8th day of February, 2022.


	By:	/s/ David P. Cohen

		David P. Cohen

Get the next $KEQU alert in real time by email

Amendment: SEC Form SC 13G/A filed by Kewaunee Scientific Corporation

Chat with this insight

Recent Analyst Ratings for
$KEQU

$KEQU
Press Releases

Fastest customizable press release news feed in the world

Kewaunee Scientific Announces Amendment to Share Repurchase Program

Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025

$KEQU
SEC Filings

SEC Form SD filed by Kewaunee Scientific Corporation

SEC Form 144 filed by Kewaunee Scientific Corporation

SEC Form 10-Q filed by Kewaunee Scientific Corporation

$KEQU
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Gehl Keith M bought $35,000 worth of shares (1,000 units at $35.00), increasing direct ownership by 6% to 18,500 units (SEC Form 4)

Director Gehl Keith M bought $22,500 worth of shares (500 units at $45.00), increasing direct ownership by 3% to 17,500 units (SEC Form 4)

Director Gehl Keith M bought $19,747 worth of shares (403 units at $49.00), increasing direct ownership by 2% to 17,000 units (SEC Form 4)

$KEQU
Financials

Live finance-specific insights

Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025

$KEQU
Large Ownership Changes

This live feed shows all institutional transactions in real time.